1. Home
  2. LXRX vs CMCO Comparison

LXRX vs CMCO Comparison

Compare LXRX & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CMCO
  • Stock Information
  • Founded
  • LXRX 1995
  • CMCO 1875
  • Country
  • LXRX United States
  • CMCO United States
  • Employees
  • LXRX N/A
  • CMCO N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CMCO Construction/Ag Equipment/Trucks
  • Sector
  • LXRX Health Care
  • CMCO Industrials
  • Exchange
  • LXRX Nasdaq
  • CMCO Nasdaq
  • Market Cap
  • LXRX 428.8M
  • CMCO 430.3M
  • IPO Year
  • LXRX 2000
  • CMCO 1996
  • Fundamental
  • Price
  • LXRX $1.09
  • CMCO $14.81
  • Analyst Decision
  • LXRX Buy
  • CMCO Hold
  • Analyst Count
  • LXRX 5
  • CMCO 1
  • Target Price
  • LXRX $3.23
  • CMCO $35.00
  • AVG Volume (30 Days)
  • LXRX 1.6M
  • CMCO 307.1K
  • Earning Date
  • LXRX 11-11-2025
  • CMCO 10-29-2025
  • Dividend Yield
  • LXRX N/A
  • CMCO 1.90%
  • EPS Growth
  • LXRX N/A
  • CMCO N/A
  • EPS
  • LXRX N/A
  • CMCO N/A
  • Revenue
  • LXRX $58,432,000.00
  • CMCO $959,221,000.00
  • Revenue This Year
  • LXRX N/A
  • CMCO $2.95
  • Revenue Next Year
  • LXRX N/A
  • CMCO $4.09
  • P/E Ratio
  • LXRX N/A
  • CMCO N/A
  • Revenue Growth
  • LXRX 1504.83
  • CMCO N/A
  • 52 Week Low
  • LXRX $0.28
  • CMCO $11.78
  • 52 Week High
  • LXRX $2.18
  • CMCO $41.05
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 47.78
  • CMCO 50.28
  • Support Level
  • LXRX $1.03
  • CMCO $14.34
  • Resistance Level
  • LXRX $1.19
  • CMCO $14.93
  • Average True Range (ATR)
  • LXRX 0.06
  • CMCO 0.55
  • MACD
  • LXRX -0.00
  • CMCO 0.02
  • Stochastic Oscillator
  • LXRX 35.29
  • CMCO 38.07

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

Share on Social Networks: